How much of aptose Biosciences'stock is owned by insiders?
Aug 06, 2021 · Aug 6, 2021 10:00AM EDT. A downtrend has been apparent in Aptose Biosciences (APTO) lately with too much selling pressure. The stock …
Who sold apto stock in the last quarter?
Dec 14, 2021 · WhatsApp. Aptose Biosciences Inc. (APTO) stock fell by a further 13% in the premarket, at $1.69 on December 14. The stock’s movement seems unaffected by the promising results of APTO’s HM43239. In last trading, the stock moved between $1.87 and $1.9972, closing at $1.9500, with a 2.01% decrease.
Will aptose Biosciences (apto) outperform or underperform the S&P 500?
Jun 11, 2021 · APTO stock closed at $5.53 and is down -$0.35 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. APTO has a roughly average overall score of 57 meaning the stock holds a better value than 57% of stocks at its current price.
Why did AT&T’s shares plunge today?
Dec 21, 2021 · Aptose Biosciences Inc (APTO) stock is trading at $1.50 as of 10:02 AM on Tuesday, Dec 21, a gain of $0.11, or 7.91% from the previous closing price of $1.39. The stock has traded between $1.46 and $1.52 so far today. Volume today is low.
Will Apto stock go up?
The 8 analysts offering 12-month price forecasts for Aptose Biosciences Inc have a median target of 8.50, with a high estimate of 13.00 and a low estimate of 3.00. The median estimate represents a +580.00% increase from the last price of 1.25.
Is Apto a good buy?
Why is Aptose Biosciences stock dropping?
Does Apto pay a dividend?
Is Aptose Biosciences a buy right now?
6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aptose Biosciences in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Aptose Biosciences stock.#N#View analyst ratings for Aptose Biosciences or view top-rated stocks.
What stocks does MarketBeat like better than Aptose Biosciences?
Wall Street analysts have given Aptose Biosciences a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aptose Biosciences wasn't one of them.
When is Aptose Biosciences' next earnings date?
Aptose Biosciences is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.#N#View our earnings forecast for Aptose Biosciences.
How were Aptose Biosciences' earnings last quarter?
Aptose Biosciences Inc. (NASDAQ:APTO) posted its earnings results on Monday, August, 2nd. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.19) by $0.04.#N#View Aptose Biosciences' earnings history.
How has Aptose Biosciences' stock price been impacted by Coronavirus (COVID-19)?
Aptose Biosciences' stock was trading at $5.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, APTO stock has decreased by 49.7% and is now trading at $2.94.#N#View which stocks have been most impacted by COVID-19.
What price target have analysts set for APTO?
6 brokerages have issued 12-month price targets for Aptose Biosciences' shares. Their forecasts range from $7.00 to $14.00. On average, they expect Aptose Biosciences' share price to reach $10.83 in the next twelve months.
What is William G. Rice, Ph.D.'s approval rating as Aptose Biosciences' CEO?
3 employees have rated Aptose Biosciences CEO William G. Rice, Ph.D. on Glassdoor.com. William G. Rice, Ph.D. has an approval rating of 34% among Aptose Biosciences' employees. This puts William G. Rice, Ph.D. in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
